GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | 8/15/2026 4:04:46 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $56,894,000 | EPS -$0.80 | ||
| LeonaBio, Inc. (LONA) | 8/14/2026 4:21:50 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $56,894,000 | EPS -$0.80 | Export Earnings Model | ||
| LeonaBio, Inc. (LONA) | 5/11/2026 4:47:28 PM | View | Proxy | SEC | Y 2025 | ||||||
| LeonaBio, Inc. (LONA) | 5/8/2026 4:02:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $71,590,000 | EPS -$1.73 | ||
| LeonaBio, Inc. (LONA) | 5/7/2026 4:19:55 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $71,590,000 | EPS -$1.73 | Export Earnings Model | ||
| LeonaBio, Inc. (LONA) | 3/31/2026 4:23:08 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $92,151,000 | EPS -$24.70 | ||
| LeonaBio, Inc. (LONA) | 3/26/2026 5:11:56 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $92,151,000 | EPS -$18.90 | Export Earnings Model | ||
| LeonaBio, Inc. (LONA) | 3/10/2026 4:22:08 PM | View | Proxy | SEC | Y 2025 | ||||||
| LeonaBio, Inc. (LONA) | 2/23/2026 4:07:52 PM | View | Proxy | SEC | Y 2025 | ||||||
| Athira Pharma, Inc. (LONA) | 11/6/2025 4:24:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $30,033,000 | EPS -$1.68 | ||
| Athira Pharma, Inc. (LONA) | 11/6/2025 4:12:00 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $30,033,000 | EPS -$1.68 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 8/8/2025 4:02:37 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $35,545,000 | EPS -$0.18 | ||
| Athira Pharma, Inc. (LONA) | 8/7/2025 4:19:35 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $35,545,000 | EPS -$0.18 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 5/9/2025 4:25:56 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $43,513,000 | EPS -$0.23 | ||
| Athira Pharma, Inc. (LONA) | 5/9/2025 4:13:05 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $43,513,000 | EPS -$0.23 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 4/14/2025 4:31:37 PM | View | Proxy | SEC | Y 2024 | ||||||
| Athira Pharma, Inc. (LONA) | 2/27/2025 4:24:35 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $58,779,000 | EPS -$2.52 | ||
| Athira Pharma, Inc. (LONA) | 2/27/2025 4:20:22 PM | View | Financials | Earnings | SEC | Y 2024 | Assets $58,779,000 | EPS -$0.39 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 11/7/2024 4:34:36 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $86,246,000 | EPS -$0.75 | ||
| Athira Pharma, Inc. (LONA) | 11/7/2024 4:16:04 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $86,246,000 | EPS -$0.75 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 8/9/2024 4:17:15 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2024 ending: 6/30/2024 | Assets $111,253,000 | EPS -$0.70 | ||
| Athira Pharma, Inc. (LONA) | 8/1/2024 4:27:57 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $111,253,000 | EPS -$0.70 | ||
| Athira Pharma, Inc. (LONA) | 8/1/2024 4:15:54 PM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $111,253,000 | EPS -$0.70 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 5/15/2024 4:38:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $133,458,000 | EPS -$0.69 | ||
| Athira Pharma, Inc. (LONA) | 5/15/2024 4:14:35 PM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $133,458,000 | EPS -$0.69 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 4/9/2024 8:33:37 AM | View | Proxy | SEC | Y 2023 | ||||||
| Athira Pharma, Inc. (LONA) | 2/22/2024 4:27:03 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $160,245,000 | EPS -$3.09 | ||
| Athira Pharma, Inc. (LONA) | 2/22/2024 4:11:14 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $160,245,000 | EPS -$0.71 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 1/8/2024 7:13:14 AM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| Athira Pharma, Inc. (LONA) | 11/9/2023 4:26:30 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $184,700,000 | EPS -$0.87 | ||
| Athira Pharma, Inc. (LONA) | 11/9/2023 4:21:51 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $184,700,000 | EPS -$0.87 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 8/10/2023 4:27:49 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $208,048,000 | EPS -$0.78 | ||
| Athira Pharma, Inc. (LONA) | 8/10/2023 4:14:32 PM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $208,048,000 | EPS -$0.78 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 5/11/2023 4:33:11 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $232,772,000 | EPS -$0.73 | ||
| Athira Pharma, Inc. (LONA) | 5/11/2023 4:17:47 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $232,772,000 | EPS -$0.73 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 4/5/2023 7:18:00 AM | View | Proxy | SEC | Y 2022 | ||||||
| Athira Pharma, Inc. (LONA) | 3/23/2023 4:31:14 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $258,153,000 | EPS -$2.53 | ||
| Athira Pharma, Inc. (LONA) | 3/23/2023 4:11:29 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $258,153,000 | EPS -$0.79 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 12/21/2022 7:01:55 AM | View | Financials | Earnings | WIRE | 3Q 2022 | Assets $274,185,000 | EPS -$0.53 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 11/10/2022 4:38:23 PM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $274,185,000 | EPS -$0.53 | ||
| Athira Pharma, Inc. (LONA) | 11/10/2022 4:18:27 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $274,185,000 | EPS -$0.53 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 8/15/2022 5:38:32 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $292,011,000 | EPS -$0.65 | ||
| Athira Pharma, Inc. (LONA) | 8/15/2022 4:40:19 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $292,011,000 | EPS -$0.65 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 5/12/2022 4:38:42 PM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $313,002,000 | EPS -$0.56 | ||
| Athira Pharma, Inc. (LONA) | 5/12/2022 4:17:46 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $313,002,000 | EPS -$0.56 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 4/11/2022 8:37:36 AM | View | Proxy | SEC | Y 2021 | ||||||
| Athira Pharma, Inc. (LONA) | 4/5/2022 4:09:52 PM | View | Proxy | SEC | Y 2021 | ||||||
| Athira Pharma, Inc. (LONA) | 3/28/2022 4:25:54 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $332,008,000 | EPS -$1.49 | ||
| Athira Pharma, Inc. (LONA) | 3/24/2022 4:13:50 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $332,008,000 | EPS -$0.44 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 11/10/2021 4:30:45 PM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $347,331,000 | EPS -$0.42 | ||
| Athira Pharma, Inc. (LONA) | 11/10/2021 4:25:14 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $347,331,000 | EPS -$0.42 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 8/16/2021 4:35:45 PM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $360,124,000 | EPS -$0.38 | ||
| Athira Pharma, Inc. (LONA) | 8/16/2021 4:20:54 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $360,124,000 | EPS -$0.38 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 5/13/2021 4:46:25 PM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $369,414,000 | EPS -$0.25 | ||
| Athira Pharma, Inc. (LONA) | 5/13/2021 4:15:53 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $369,414,000 | EPS -$0.25 | Export Earnings Model | ||
| Athira Pharma, Inc. (LONA) | 4/16/2021 6:07:09 AM | View | Proxy | SEC | Y 2020 | ||||||
| Athira Pharma, Inc. (LONA) | 3/25/2021 7:01:44 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $279,563,000 | EPS -$1.67 | ||
| Athira Pharma, Inc. (LONA) | 11/12/2020 4:26:24 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $267,939,000 | EPS -$1.12 | ||
| Athira Pharma, Inc. (LONA) | 11/12/2020 4:17:30 PM | View | Earnings | SEC | 3Q 2020 | Assets $267,939,000 | EPS -$1.12 |